Gene Therapy using anti-inflammatory cytokines promising against MS

30 January 2018


BioViva scientist Ali Fallah and his team work on novel gene therapy using anti-inflammatory cytokines and show that these can be a promising approach against multiple sclerosis (MS).

Source:  Cell Journal.

Leave a Reply